| MERID |
Inhibitor |
Inhibitor name |
Ki |
Conditions |
Reference |
| I02.036 |
FhKT1 (Fasciola hepatica) |
|
|
|
Smith et al., 2020 |
| I04.008 |
squamous cell carcinoma antigen 1 |
|
|
|
Sakata et al., 2004 |
| I04.041 |
serpin srp-2 (Caenorhabditis elegans) |
|
|
|
Pak et al., 2002 |
| I25.001 |
cystatin A |
|
0.05 nM |
|
Abrahamson, 1994 |
| I25.003 |
cystatin B |
|
0.07 nM |
|
Abrahamson, 1994 |
| I25.004 |
cystatin C |
|
0.008 nM |
|
Abrahamson, 1994 |
| I25.005 |
cystatin D |
|
0.24 nM |
|
Abrahamson, 1994 |
| I25.014 |
phytocystatin |
CaneCPI-2 |
0.28 nM |
|
Shibao et al., 2020 |
| I25.014 |
phytocystatin |
CaneCPI-3 |
3.23 nM |
|
Shibao et al., 2020 |
| I25.014 |
phytocystatin |
CaneCPI-5 |
0.82 nM |
|
Shibao et al., 2020 |
| I25.014 |
phytocystatin |
CaneCPI-6 |
24 nM |
|
Shibao et al., 2020 |
| I25.014 |
phytocystatin |
CPI-2 ({Citrus sinensis}) |
0.11 nM |
|
Schneider et al., 2020 |
| I25.045 |
caneCPI cystatin (Saccharum sp.) |
CaneCPI-4 |
4.38 nM |
|
Shibao et al., 2020 |
| I25.049 |
sialostatin L (Ixodes scapularis) |
ricistatin ({Ixodes ricinus}) |
34.4 nM |
|
Martins et al., 2023 |
| I25.051 |
cystatin Hv-CPI1 (Hordeum vulgare) |
CaneCPI-1 |
30 nM |
|
Shibao et al., 2020 |
| I25.054 |
cystatin Hv-CPI5 (Hordeum vulgare) |
CPI-1 ({Citrus clementina}) |
0.29 nM |
|
Schneider et al., 2020 |
| I25.064 |
cystatin RHcyst-1 (Rhipicephalus haemaphysaloides) |
Rhcyst-1 |
|
|
<%Wang et al., 2015%> |
| I25.UPA |
subfamily I25A unassigned peptidase inhibitors |
FhCyLS-2 ({Fasciola hepatica}) |
|
|
Busa et al., 2023 |
| I25.UPB |
subfamily I25B unassigned peptidase inhibitors |
CPI-1 ({Citrus sinensis}) |
8.2 nM |
|
Schneider et al., 2020 |
| I25.UPB |
subfamily I25B unassigned peptidase inhibitors |
CPI-2 ({Citrus clementina}) |
0.36 nM |
|
Schneider et al., 2020 |
| I25.UPB |
subfamily I25B unassigned peptidase inhibitors |
CPI-3 ({Citrus clementina}) |
0.56 nM |
|
Schneider et al., 2020 |
| I29.001 |
cathepsin L propeptide |
|
65 nM |
|
Guay et al., 2000 |
| I29.004 |
cathepsin S propeptide |
|
7.6 nM |
|
Guay et al., 2000 |
| I29.007 |
cathepsin K propeptide |
|
3.6-6.3 nM |
|
Guay et al., 2000 |
| I29.010 |
cathepsin V propeptide |
|
10.7 nM |
|
Burden et al., 2007 |
| I48.001 |
clitocypin |
|
3.2 nM |
natural inhibitor |
Sabotic et al., 2009 |
| I85.001 |
macrocypin 1 |
|
47.1 nm |
natural inhibitor |
Sabotic et al., 2009 |
| I85.002 |
macrocypin 3 |
|
5.1 nm |
recombinant form |
Sabotic et al., 2009 |
| I85.003 |
macrocypin 4 |
|
6.3 nm |
recombinant form |
Sabotic et al., 2009 |
|
paecilopeptin |
|
|
|
Shindo et al., 2002 |
|
JNJ 10329670 |
|
30 nM |
|
Thurmond et al., 2004 |
|
CSI-75 |
|
|
|
Baugh et al., 2011 |
|
LY3000328 |
|
|
|
Payne et al., 2014 |
|
RO5444101 |
|
|
|
Figueiredo et al., 2015 |
|
RO5459072 |
|
|
|
Theron et al., 2017 |
|
small-molecule inhibitors of cysteine peptidases |
Z-Phe-Gly-NHO-Bz |
|
|
|
|
small-molecule inhibitors of cysteine peptidases |
non-covalent 2-(benzoxazol-2- ylamino)-acetamide |
|
|
Tully et al., 2006 |
|
small-molecule inhibitors of cysteine peptidases |
N-[(1R)-1-[(benzylsulfonyl)methyl]-2-{[(1S)-1-methyl-2-{[4-(trifluoromethoxy)phenyl]amino}ethyl]amino}-2-oxoethyl]morpholine-4-carboxamide |
32 nM |
|
Tully et al., 2006 |
|
small-molecule inhibitors of cysteine peptidases |
a novel 2- arylphenoxyacetaldehyde inhibitor derived by the substrate activity screening (sas) method |
490 nM |
|
Inagaki et al., 2007 |
|
small-molecule inhibitors of cysteine peptidases |
morpholine-4-carboxylic acid {(S)-1-[4-cyano-1-(3-morpholin-4-yl-propyl)-piperidin-4-ylcarbamoyl]-4,4-dimethyl-hexyl}-amide |
|
|
McGrath et al., 1998 |
|
small-molecule inhibitors of cysteine peptidases |
RO5461111 |
|
|
Rupanagudi et al., 2013 |
|
small-molecule inhibitors of cysteine peptidases |
SAR114137 |
|
|
Feth et al., 2013 |
|
small-molecule inhibitors of cysteine peptidases |
N-CBZ-piperidyl derivative 2 |
|
|
Yuan et al., 2018 |
|
small-molecule inhibitors of cysteine peptidases |
ortho-benzyloxyl phenylacetyl derivative 1 |
|
|
Yuan et al., 2018 |
|
small-molecule inhibitors of cysteine peptidases |
p-toluenesulfonyl derivative 3 |
|
|
Yuan et al., 2018 |
|
small-molecule inhibitors of cysteine peptidases |
methyl ((R)-2,5-dioxopyrrolidin-3-yl)-l-threoninate (compound R-4c) |
|
|
Gorican et al., 2021 |
|
small-molecule inhibitors of cysteine peptidases |
3-{[(1S,2R,3'S)-2-hydroxycyclohexyl]amino}pyrrolidine-2,5-dione (compound (1S,2R,3'S-10) |
|
|
Gorican et al., 2021 |
|
small-molecule inhibitors of cysteine peptidases |
SPR38 |
|
|
Previti et al., 2025 |
|
small-molecule inhibitors of cysteine peptidases |
SPR39 |
|
|
Previti et al., 2025 |
|
small-molecule inhibitors of cysteine peptidases |
SPR41 |
|
|
Previti et al., 2025 |
|
aldehyde, ketone, glyoxal, or semicarbazone inhibitors of cysteine peptidases |
dipeptide nitrile inhibitor BLN |
|
|
Ward et al., 2002 |
|
aldehyde, ketone, glyoxal, or semicarbazone inhibitors of cysteine peptidases |
Z-FL-COCHO |
0.185 nM |
|
Walker et al., 2000 |
|
nitrile inhibitors of cysteine peptidases |
compound 12 |
4.02 nM |
|
Lemke et al., 2020 |
|
nitrile inhibitors of cysteine peptidases |
compound 24 |
35.5 nM |
|
Lemke et al., 2020 |
|
CLIK-060 |
CLIK-60 |
|
|
Katunuma et al., 2003 |
|
CLIK-060 |
|
|
|
Katunuma et al., 1999 |
|
ZFL |
|
185 pM |
|
|
|
DCG-04 biotinylated epoxide |
|
|
|
Greenbaum et al., 2000 |
|
BIL-DMK diazomethane inhibitor of cysteine peptidases |
|
|
|
Falgueyret et al., 2004 |
|
BIL-DMK diazomethane inhibitor of cysteine peptidases |
Z-Phe-Ala fluoromethyl ketone |
|
|
|
|
Z-DEVD-FMK |
z-DEVD-cmk |
|
k2/K1 = 28100 M-1s-1 |
Rozman-Pungercar et al., 2003 |
|
Ac-YVAD-CMK |
|
|
k2/K1 = 6900 M-1s-1 |
Rozman-Pungercar et al., 2003 |
|
Ac-YVAD-CMK |
Z-Val-Ala-Asp-CH(2)F |
|
k2/K1 = 160 M-1s-1 |
Rozman-Pungercar et al., 2003 |
|
MK-0674 |
|
|
|
Isabel et al., 2010 |
|
vinyl sulfone or other Michael acceptor inhibitors of cysteine peptidases |
morpholyl-cyAla-hPhe-F-vinylsulfonate-Ph compound 6c |
0.08 nM |
|
Fuchs et al., 2023 |
|
APC2848 |
|
18 nM |
|
Bromme et al., 1996 |
|
LHVS |
|
|
|
Clark et al., 2007 |
|
benzamidine derivatives |
N-cyano-4-ethyl-N-(4-sulfamoylphenyl)benzamide |
0.28 muM |
|
Abdoli et al., 2023 |
|
benzamidine derivatives |
Benzydamine |
|
|
Zhang et al., 2024 |